Reuters: Health News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.

Reuters News
  • India not treating AIDS patients early: Global Fund
    NEW DELHI (Reuters) - Thousands of AIDS patients in India are not receiving treatment on time, underscoring huge challenges the country faces as it combats the disease, the Global Fund To Fight AIDS, Tuberculosis and Malaria said on Thursday.


  • Study backs prostate screening for high risk men
    LONDON (Reuters) - Men who have a certain genetic variations that put them at higher risk of prostate cancer may benefit from regular screening for the disease, a study by British scientists found Friday.


  • Risks of old, new diet drugs face U.S. scrutiny
    WASHINGTON (Reuters) - The risks of a potential new diet pill and a 13-year-old weight-loss medicine face U.S. scrutiny next week as medical experts consider if the drugs' benefits outweigh possible side effects.


  • FDA cracks down on 5 makers of e-cigarettes
    CHICAGO (Reuters) - The U.S. Food and Drug Administration sent warnings to five makers of electronic cigarettes for marketing them illegally as stop-smoking aids and said on Thursday it intends to regulate the products as drugs.


  • UK's NICE wants more data on BMS schizophrenia drug
    LONDON (Reuters) - Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has asked for more information on its effectiveness.



About ResearchInformatics.org

ResearchInformatics.org is an open-access portal for discussion, information sharing, and collaboration among those working to advance the rapidly developing field of clinical research informatics (CRI). We hope that you find the content useful and that you use our interactive features to contribute your knowledge and experience for the benefit of our community. If you haven't already done so, please register to take full advantage of the site's resources.